|

Hypericin Clinical Trials

1 actively recruiting trial across 1 location

Also known as: HyBryte, SGX301

Pipeline

Phase 3: 1

Top Sponsors

  • Soligenix1

Indications

  • CTCL1
  • CTCL/ Mycosis Fungoides1
  • Mycosis Fungoides1
  • Cutaneous T Cell Lymphoma1
  • Cancer1

Phoenix, Arizona1 trial

Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL

Medical Dermatology Specialists

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.